Skip to main content
New Frontiers in Healthcare
Thursday, 14 November 2024 16:00 CET

Past Event

In-person

.

CET

New Frontiers in Healthcare

Connecting Switzerland and UK's Global Life Science Expertise

Come together at the forefront of change 
 

Beyond a meeting point for professionals across the pharma, tech, finance, professional services, and public policy sector, this event is a platform for leaders to come together at the frontiers of change and deepen collaboration. Key discussion themes include patient-centric equitable healthcare solutions, AI enabled resilient healthcare systems and the strategic risks posed by geopolitical instability and climate change. A line-up of distinguished speakers and panellists will provide thought-provoking insights into these critical issues. Deloitte will share key findings from our latest research publication, Life Sciences and Healthcare Predictions 2030.

Connect with stakeholders from the Swiss health ecosystem and international peers to explore collective efforts that can drive tangible strategies for the most pressing healthcare challenges.

Around the world, healthcare systems are facing challenges. An ageing population and staffing shortages are straining health ecosystems, leading to increased demand for services, overburdened healthcare workers, rising cost and unequal access to healthcare.  The demand for systems that are both innovative and equitable has never been more critical. How can organisations prepare for the changes ahead? 

At the New Frontiers in Healthcare event, Deloitte will dive into ten predictions exploring how the world could look in 2030. Based on our latest research publication Life Sciences and Healthcare Prediction 2030, we discuss how the future feels like for different stakeholders in the health ecosystem, using the evidence today to inform our views of tomorrow and how AI technologies, specifically GenAI, might help bring a more equitable and patient-centric future closer.  

Date:

14 November 2024, 16:00 - 21:00

Location:

Swiss Innovation Park Basel

Agenda:

16:00 Registration

16:30 Welcome from British Swiss Chamber of Commerce

  • Manu Chhokra, Basel Chapter Chair
  • The British-Swiss Chamber of Commerce

16:35 Opening remarks

16:50 Keynote Address | Life Sciences & Healthcare Predictions 2030

  • Alexander Mirow, Partner in Life Sciences and Industry Consulting Lead, Deloitte
  • Patricia Gee, Partner in Life Sciences and Leader Future of Health, Deloitte
17:10 Panel 1 | Equitable Healthcare Patient Experience
  • Peter Speyer, Head of Data & Analytic, Novartis Foundation
  • Sanjay Rishi, Global Product Development Diversity & Inclusion Lead, F. Hoffmann - La Roche
  • Moderated by: Elizabeth Hampson, Partner, Life Sciences and Health Innovation Strategy, Deloitte

17:50 Panel 2 | Ensuring & Driving Healthcare System Resilience

  • Stéphanie Chuffart-Finsterwald, Attorney-at-law IP, Data and LS Partner, Schellenberg Wittmer 

18:30 Panel 3 | The Geopolitical Environment

  • Henning Gloystein, Energy, Climate, Resources, Eurasia Group
  • Anthony Kennaway, Head Group Public Affairs, Swiss Re
  • Nathalie Stieger, Head of Group Government Affairs, F. Hoffmann - La Roche
  • Randall McGuire, Director Geopolitics & Life Science Innovation, Novartis
  • Moderated by: Nico Luchsinger, Executive Director, Asia Society 

19:05 Event Wrap Up and Vote of Thanks

19:15 Networking Apéro

21:30 End 

 

For more information on the agenda, visit the British Swiss Chamber of Commerce website here Agenda - New Frontiers in Healthcare

Our experts

Patricia Gee

Deloitte - Switzerland
Patricia leads Deloitte’s Future of Health initiative in Switzerland. She has spent over 15 years in the life science and health industry, bringing together cross-sector experience in biopharma, payer, provider and capital markets. She focuses on driving sustainable value, growth and innovation for leading life science clients by creating commercial portfolio and business unit strategies, designing and developing customer-centric solutions and deploying commercial excellence programs.
View Profile

Alexander Mirow

Deloitte - Switzerland
Alexander has 18 years of experience partnering with Global Life Sciences executives developing and deploying product launch strategies and transforming functions such as Market Access & Pricing, Marketing & Digital Customer Engagement and Evidence Generation. He has broad therapeutic area experience, ranging from oncology over cardiovascular, inflammation to rare diseases, designing go-to-market strategies and patient pathway innovation. Alexander leads Switzerland’s Strategy and Business Design practice and serves as Consulting Industry Lead for Life Sciences in Switzerland.
View Profile